Alzinova ABOSTO:ALZ +0.55%21 EV-to-FCF is -2.25 as of Jun. 28, 2026. GuruFocus rates OSTO:ALZ with a GF Score™ of 21/100. The stock has 1 warning sign investors should review. Among 336 Biotechnology companies, Alzinova AB ranks worse than 297618.75% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Alzinova AB's Enterprise Value is kr110.92 Mil.
Alzinova AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was kr-49.39 Mil. Therefore, Alzinova AB's EV-to-FCF for today is -2.25.
The historical rank and industry rank for Alzinova AB's EV-to-FCF or its related term are showing as below:
OSTO:ALZ'
s EV-to-FCF Range Over the Past 10 Years
Min: -8.93 Med: -3.02 Max: -0.57
Current: -2.25
During the past 10 years, the highest EV-to-FCF of Alzinova AB was -0.57. The lowest was -8.93. And the median was -3.02.
OSTO:ALZ's EV-to-FCF is ranked worse than 100% of 336
companies
in the Biotechnology industry
Industry Median: 14.7
vs OSTO:ALZ: -2.25
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Alzinova AB's PE Ratio (TTM) for today is calculated as:
Alzinova AB's share price for today is kr0.545.
Alzinova AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.270.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Alzinova AB EV-to-FCF Related Terms
Alzinova AB EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Alzinova AB's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ALZ vs VRTX, REGN, ALNY: EV-to-FCF Comparison
For the Biotechnology subindustry, Alzinova AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alzinova AB EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Alzinova AB's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Alzinova AB's EV-to-FCF falls into.
Alzinova AB's current Enterprise Value is kr110.92 Mil.
Alzinova AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-49.39 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alzinova AB (OSTO:ALZ) has a EV-to-FCF of -2.25 as of Jun. 28, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Alzinova AB and its competitors. According to the industry distribution chart, Alzinova AB ranks #999999 out of 336 companies in the Biotechnology industry.
Is Alzinova AB's EV-to-FCF too high?
Alzinova AB's current EV-to-FCF is -2.25. Based on the distribution chart, Alzinova AB ranks #999999 out of 336 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Alzinova AB has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Alzinova AB's EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Alzinova AB ranks #999999 out of 336 companies for EV-to-FCF. This places Alzinova AB in the lower half of its industry. The industry median EV-to-FCF is 14.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 14.70, based on 336 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Alzinova AB and its competitors. For the Biotechnology industry, the median EV-to-FCF is 14.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alzinova AB's current EV-to-FCF is -2.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alzinova AB stock overvalued right now?
Alzinova AB (OSTO:ALZ) has a current EV-to-FCF of -2.25. The current EV-to-FCF is -2.25. Alzinova AB's overall GF Score™ is 21/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Alzinova AB (OSTO:ALZ), the current EV-to-FCF is -2.25 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is developing ALZ-101, an oligomer-specific therapeutic vaccine currently advancing toward Phase 2 clinical development, and ALZ-201, a monoclonal antibody targeting toxic amyloid-beta (AB) oligomers, which is in preclinical development. The company's proprietary ABCC peptide technology is focused on disease-modifying treatments for Alzheimer's disease.
21GF Score
Get the complete analysis for OSTO:ALZ
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ALZ has been successfully added to your 
